Live Breaking News & Updates on Esmo Io Virtual Congress
Stay updated with breaking news from Esmo io virtual congress. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
F. Hoffmann-La Roche Ltd: Roche presents exploratory data from the Phase III IMvigor010 study in early bladder cancer at the ESMO Immuno-Oncology Virtual Congress 2020 25.8 DFS, HR (95% CI) (0.19-0.60) About bladder cancer and muscle-invasive urothelial cancer In 2018, there were over half a million new cases of bladder cancer diagnosed globally, with approximately 200,000 deaths from the disease. 4 Urothelial cancer is the most common type of bladder cancer, accounting for about 90-95% of all cases. 5 MIUC is a type of urothelial cancer that has spread into the muscle of the bladder, ureter or renal pelvis. 6 Approximately 25% of new cases of bladder cancer are diagnosed with muscle-invasive disease, ....
F. Hoffmann-La Roche Ltd Roche presents exploratory data from the Phase III IMvigor010 study in early bladder cancer at the ESMO Immuno-Oncology Virtual Congress 2020 Roche presents exploratory data from the Phase III IMvigor010 study in early bladder cancer at the ESMO Immuno-Oncology Virtual Congress 2020 People with muscle-invasive urothelial cancer (MIUC) who had detectable circulating tumour DNA (ctDNA) were more likely to benefit from treatment with adjuvant (after surgery) Tecentriq monotherapy, compared with those without ctDNA The goal of current treatment in people with MIUC is to provide early intervention to reduce the risk of the disease recurring or spreading to other parts of the body ....